US EditionNovo Nordisk cuts hit production line jobs at key US plant: Reuters
Dozens of layoffs at Novo Nordisk's Clayton plant target manufacturing roles amid a global plan to cut 9,000 jobs due to slowing growth and competition from Eli Lilly.
- Last month, Novo Nordisk let go dozens of workers at its largest US manufacturing site in Clayton, North Carolina after a Reuters review of LinkedIn posts revealed the cuts.
- Facing slowing growth, the company is trimming staff that bloated during the Wegovy boom to cut costs and confront stiff competition from rival Eli Lilly.
- At Clayton, affected functions ranged from technical manufacturing to project coordination and communications, hitting workers involved in semaglutide production and filling, finishing, and packaging.
- When contacted, about 30 employees responded to Reuters and one cited an NDA, while a Novo Nordisk spokesperson said `This process takes time and our highest priority is to support our employees`.
- The restructuring plans to cut 9,000 jobs worldwide by the end of 2026, while CEO Mike Doustdar this month announced a $4.1 billion expansion at the North Carolina plant with 2,500 employees in 2024 and 1,000 additional expected.
10 Articles
10 Articles
Exclusive: Novo Nordisk cuts hit production line jobs at key US plant, posts show
The previously unreported cuts included staff in manufacturing roles, from quality control to production line technicians, at Novo's major Clayton, North Carolina, plant and other facilities in the state.
Deductions, although only a small part of a total of 9 000 jobs cuts, highlight how New is even reducing front line production in Wegovy's main market
Ozempic Maker Novo Nordisk Plans to Cut 150 Jobs in India
The Danish pharmaceutical company intends to reduce 11% of its workforce, or 9,000 positions, in order to save 8 billion Danish krone ($1.25 billion) a year. Indian workers in Bengaluru have been laid off less than a month after Ozempic manufacturer Novo Nordisk declared it was reducing its worldwide workforce as part of a reorganisation strategy.At least three people who are aware of the development reported to Mint, saying that it has affected…
Coverage Details
Bias Distribution
- 80% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
